Milhealth's Directory of Military Health Information Resources

Is Current Body Armor Enough Protection for our Troops?

Trauma Attenuating Backing Improves Protection Against Behind Armor Blunt Trauma

Abstract

Background: Body armor is used by military personnel, police officers, and security guards to protect them from fatal gunshot injuries to the thorax. The protection against high-velocity weapons may, however, be insufficient. Complementary trauma attenuating backings (TAB) have been suggested to prevent morbidity and mortality in high-velocity weapon trauma.

Brain Activity in Disorders of Consciousness-Meaurement with MRI

Willful Modulation of Brain Activity in Disorders of Consciousness

ABSTRACT

Background The differential diagnosis of disorders of consciousness is challenging. The rate of misdiagnosis is approximately 40%, and new methods are required to complement bedside testing, particularly if the patient's capacity to show behavioral signs of awareness is diminished.

SIDS-Sudden Infant Death Syndrome and Brainstem Serotonergic Deficiency

Brainstem Serotonergic Deficiency in Sudden Infant Death Syndrome

Context  Sudden infant death syndrome (SIDS) is postulated to result from abnormalities in brainstem control of autonomic function and breathing during a critical developmental period. Abnormalities of serotonin (5-hydroxytryptamine [5-HT]) receptor binding in regions of the medulla oblongata involved in this control have been reported in infants dying from SIDS.

d-Cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window

Neuropharmacology and Analgesia

d-Cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window

Abstract

It has been long thought that hyperactivation of N-methyl-d-aspartate (NMDA) receptors underlies neurological decline after traumatic brain injury. However, all clinical trials with NMDA receptor antagonists failed. Since NMDA receptors are down-regulated from 4 h to 2 weeks after brain injury, activation at 24 h, rather than inhibition, of these receptors, was previously shown to be beneficial in mice.

Comorbidity and the Treatment of Principal Anxiety Disorders

Comorbidity and the Treatment of Principal Anxiety Disorders in a Naturalistic Sample 

Abstract:

This study examined the impact of comorbidity on treatment outcome and the effects of cognitive behavioral therapy (CBT) for anxiety and depressive disorders on comorbid disorders in a naturalistic sample of 150 patients presenting to an anxiety disorders clinic.